Patent ID: 6107304
Filing Date: 2000-08-22
Classification: A61P,C07D

Abstract:
A compound selected from a group consisting of:2,3-Dihydro-4-methyl-1H-[1]benzothieno[2,3-b]pyrazolo[3,4-d]pyridin-3-one and pharmaceutically acceptable salts, hydrates and solvates thereof;A pharmaceutically acceptable salt, hydrate or solvate of 2,3,7,8,9,10-Hexahydro-4-methyl-1H-[1]benzothieno[2,3-b]pyrazolo[3,4-d]pyr idin-3-one;1,4-Dimethyl-8,8-ethylenedioxy-2,3,7,8,9,10-hexahydro-1H-[1]benzothieno[2,3 -b]pyrazolo[3,4-d]pyridin-3-one and pharmaceutically acceptable salts, hydrates and solvates thereof;A pharmaceutically acceptable salt, hydrate or solvate of 8,8-Ethylenedioxy-2,3,7,8,9,10-hexahydro-4-methyl-1H-[1]benzothieno[2,3-b] pyrazolo[3,4-d]pyridin-3-one;8-tert-Butoxycarbonyl-2,3,7,8,9,10-hexahydro-4-methyl-1H-pyrido[4',3':4,5]t hieno[2,3-b]pyrazolo[3,4-d]pyridin-3-one and pharmaceutically acceptable salts, hydrates and solvates thereof; and2,3,7,8,9,10-Hexahydro-4-methyl-1H-pyrido[4',3':4,5]thieno[2,3-b]pyrazolo[3 ,4-d]pyridin-3-one and pharmaceutically acceptable salts, hydrates and solvates thereof.